newsfilter
← Latest News
GlobeNewswire·

Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08

TDOC
  • Teladoc Health, Inc. issued inducement awards to Michael Grasher effective September 1, 2026, upon his commencement as Chief Financial Officer.
  • Grasher received 239,616 restricted stock units (RSUs) covering common stock with a $0.001 par value.
  • Grasher was granted performance stock units (PSUs) with a target of 239,616 shares, allowing for a maximum earnout of 479,232 shares.
  • RSUs vest with 50% on the first anniversary of the grant date, with the remainder vesting in six equal quarterly installments starting at the 15-month anniversary.
  • EBITDA-based PSUs vest 50% on the first anniversary, with the rest vesting in six equal quarterly installments starting at the 15-month anniversary.
  • Revenue CAGR-based PSUs vest entirely on March 1, 2029.
  • EBITDA PSUs are based on Teladoc Health's adjusted EBITDA for 2026.
  • Revenue CAGR PSUs are based on the company's compound annual revenue growth rate during 2026-2028.
  • The awards were approved by the Compensation Committee under the 2023 Employment Inducement Incentive Award Plan pursuant to NYSE Rule 303A.08.